title: The potential of Physcomitrella patens as a platform for the production of plant-based vaccines.
abstract: The moss Physcomitrella patens has a number of advantages for the production of biopharmaceuticals, including: i) availability of standardized conditions for cultivation in bioreactors; ii) not being part of the food chain; iii) high biosafety; iv) availability of highly efficient transformation methods; v) a haploid, fully sequenced genome providing genetic stability and uniform expression; vi) efficient gene targeting at the nuclear level allows for the generation of mutants with specific post-translational modifications (e.g., glycosylation patterns); and vii) oral formulations are a viable approach as no toxic effects are attributed to ingestion of this moss. In the light of this panorama, this opinion paper analyzes the possibilities of using P. patens for the production of oral vaccines and presents some specific cases where its use may represent significant progress in the field of plant-based vaccine development. The advantages represented by putative adjuvant effects of endogenous secondary metabolites and producing specific glycosylation patterns are highlighted.
authors.affiliation: Laboratorio de Biofarmacéuticos Recombinantes, Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava 6, SLP, 78210, México.
authors.forename: Sergio
authors.initials: S
authors.lastname: Rosales-Mendoza
authors.forename: Lucía
authors.initials: L
authors.lastname: Orellana-Escobedo
authors.forename: Andrea
authors.initials: A
authors.lastname: Romero-Maldonado
authors.forename: Eva L
authors.initials: EL
authors.lastname: Decker
authors.forename: Ralf
authors.initials: R
authors.lastname: Reski
mesh_terms: D000284:Administration, Oral; D001709:Biotechnology / Q000379:methods; D019068:Bryopsida / Q000235:genetics / Q000378:metabolism*; D006801:Humans; D030821:Plants, Genetically Modified; D013678:Technology, Pharmaceutical / Q000379:methods*; D014612:Vaccines / Q000276:immunology* / Q000378:metabolism*
chemical_list: D014612:Vaccines